Annovis Bio is up 16.5%, or $1.07 to $7.57.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ANVS:
- Annovis Bio rises 9.2%
- Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original Projections
- Annovis Bio announces full enrollment in Phase II/III Alzheimer’s disease trial
- Annovis Bio price target lowered to $30 from $40 at H.C. Wainwright
- Annovis Bio initiated with a Buy at Brookline